Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp
- Conditions
- Actinic Keratosis
- Interventions
- First Posted Date
- 2017-01-18
- Last Posted Date
- 2017-11-07
- Lead Sponsor
- DUSA Pharmaceuticals, Inc.
- Registration Number
- NCT03024060
- Locations
- 🇺🇸
Shideler Clinical Research Center, Carmel, Indiana, United States
🇺🇸Altman Dermatology Associates, Arlington Heights, Illinois, United States
🇺🇸Therapeutics Clinical Research, San Diego, California, United States
Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face
- Conditions
- Actinic Keratosis
- Interventions
- Drug: Topical Solution VehicleDevice: IBL 10 mWDevice: IBL 20 mWProcedure: Microneedle lesion preparation
- First Posted Date
- 2015-12-16
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- DUSA Pharmaceuticals, Inc.
- Target Recruit Count
- 137
- Registration Number
- NCT02632110
- Locations
- 🇺🇸
Minnesota Clinical Study Center, Fridley, Minnesota, United States
🇺🇸Virginia Clinical Research, Inc., Norfolk, Virginia, United States
🇺🇸UCSD Dermatology, San Diego, California, United States
Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
- Conditions
- Keratosis, Actinic
- Interventions
- Drug: Aminolevulinic Acid (ALA)Device: BLU-U
- First Posted Date
- 2015-12-11
- Last Posted Date
- 2017-09-18
- Lead Sponsor
- DUSA Pharmaceuticals, Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT02628236
- Locations
- 🇺🇸
J&J Studies, Inc, College Station, Texas, United States
🇺🇸DermResearch, Inc., Austin, Texas, United States
Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick
- Conditions
- Keratosis, Actinic
- Interventions
- Drug: Aminolevulinic Acid (ALA)Device: BLU-U
- First Posted Date
- 2014-11-02
- Last Posted Date
- 2017-01-13
- Lead Sponsor
- DUSA Pharmaceuticals, Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT02281136
- Locations
- 🇺🇸
Therapeutics Clinical Research, San Diego, California, United States
🇺🇸Shideler Clinical Research Center, Carmel, Indiana, United States
🇺🇸DermResearch, Inc., Austin, Texas, United States
Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy
- Conditions
- Actinic Keratosis
- Interventions
- First Posted Date
- 2014-09-15
- Last Posted Date
- 2018-08-24
- Lead Sponsor
- DUSA Pharmaceuticals, Inc.
- Target Recruit Count
- 166
- Registration Number
- NCT02239679
- Locations
- 🇺🇸
UCSD Dermatology, San Diego, California, United States
🇺🇸Sadick Research Group, New York, New York, United States
🇺🇸Shideler Clinical Research Center, Carmel, Indiana, United States
Twelve Month Follow-Up of CP0108
- Conditions
- Actinic Keratosis
- Interventions
- Drug: Aminolevulinic Acid (ALA)Drug: Topical Solution VehicleDevice: BLU-U Blue Light Photodynamic Therapy Illuminator
- First Posted Date
- 2014-08-05
- Last Posted Date
- 2016-09-23
- Lead Sponsor
- DUSA Pharmaceuticals, Inc.
- Target Recruit Count
- 206
- Registration Number
- NCT02209012
- Locations
- 🇺🇸
Virginia Clinical Research, Inc., Norfolk, Virginia, United States
🇺🇸Shideler Clinical Research Center, Carmel, Indiana, United States
🇺🇸Center For Dermatology Clinical Research, Inc., Fremont, California, United States
Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities
- Conditions
- Actinic Keratosis
- Interventions
- Drug: Aminolevulinic Acid (ALA)Drug: Topical Solution VehicleDevice: Blue Light Photodynamic Therapy Illuminator (BLU-U)
- First Posted Date
- 2014-05-14
- Last Posted Date
- 2015-09-16
- Lead Sponsor
- DUSA Pharmaceuticals, Inc.
- Target Recruit Count
- 269
- Registration Number
- NCT02137785
- Locations
- 🇺🇸
Oregon Dermatology and Research Center, Portland, Oregon, United States
🇺🇸Virginia Clinical Research, Inc., Norfolk, Virginia, United States
🇺🇸Center for Clinical and Cosmetic Research, Aventura, Florida, United States
Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)
- Conditions
- Actinic Keratosis
- Interventions
- Drug: Broad Area ALA 1-hour incubationDrug: Broad Area ALA 2 hour incubationDrug: broad area ALA 3-hour incubationDrug: Vehicle PDTDevice: Blue Light Treatment
- First Posted Date
- 2011-11-22
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- DUSA Pharmaceuticals, Inc.
- Target Recruit Count
- 235
- Registration Number
- NCT01475955
- Locations
- 🇺🇸
Therapeutics Clinical Research, San Diego, California, United States
🇺🇸Northwest Clinical Trials, Inc., Boise, Idaho, United States
🇺🇸Altman Dermatology Associates, Arlington Heights, Illinois, United States
Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)
- Conditions
- Keratosis, Actinic
- Interventions
- Drug: Aminolevulinic Acid PDT (ALA)Drug: Vehicle PDT (VEH)
- First Posted Date
- 2011-10-25
- Last Posted Date
- 2013-03-14
- Lead Sponsor
- DUSA Pharmaceuticals, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT01458587
- Locations
- 🇺🇸
Therapeutics Clinical Research, San Diego, California, United States
🇺🇸Park Avenue Dermatology, PA, Orange Park, Florida, United States
🇺🇸DermResearch, Inc, Austin, Texas, United States
ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients
- Conditions
- Actinic KeratosesSkin Neoplasms
- Interventions
- Other: Vehicle
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2011-10-21
- Lead Sponsor
- DUSA Pharmaceuticals, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT00865878
- Locations
- 🇺🇸
The Mount Sinai Medical Center, New York, New York, United States
🇺🇸University of California, Irvine, Irvine, California, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States